Zimbabwe has declined a major American health deal valued at 367 million US dollars (272 million pounds) spanning five years over Washington's demand for sensitive information.
This move was revealed following a internal memorandum from December was leaked, which showed Head of State Emmerson Mnangagwa felt the arrangement was "lopsided".
An official spokesman has since clarified that the US was seeking genetic material for scientific study and commercial gain but refused to share the resulting advantages from future treatments.
"We will now turn to the challenging and unfortunate task of ending our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the United States had provided over $1.9bn in health funding to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has called for further dialogue to reach a deal agreeable to both sides so the nation's vital HIV programme can continue.
Broader Background
Zimbabwe's decision comes after a comparable case in neighbouring Kenya, where a court halted a related deal with the US following legal challenges were raised about the safety of Kenyans' health data.
After resuming the presidency recently, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.
USAID had managed aid for the US government, but Trump stated its spending was "wasteful" and his administration was pursuing government-to-government agreements to boost openness and responsibility.
Based on statements, Sixteen African countries have so far signed similar agreements, constituting more than $18.3bn of fresh investment.
Specifics of the Declined Agreement
The funds for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this partnership might have yielded significant advantages for Zimbabwean communities, especially the 1.2 million men, women and children currently on HIV treatment via American-funded initiatives," Tremont said.
However, official spokesman Nick Mangwana said the proposed deal was "asymmetrical".
"Our nation was requested to share its biological resources and data indefinitely, with no corresponding promise of benefiting from any medical innovations – like new medicines or tests – that might be developed from that provided information," he stated.
"Put simply, our country would provide the raw materials for medical research without any assurance that the final treatments would be accessible to our population should a future health crisis arise."
National Interest and Global Health
Mangwana further noted that the US's withdrawal from the global health body and its pursuit of bilateral deals were upending structures already established through the global organization.
Mangwana cited its Pathogen Access and Benefit Sharing framework created to manage potential global health emergencies.
"This mechanism is intended to guarantee that when a country provides its information, the benefits – such as vaccines and treatments – are shared equitably, not commercialised exclusively by those with the funds to develop them."
These objections regarding the US deal "must not be interpreted as anti-American sentiment," he added.
"We are open to continued dialogue with our American counterparts on how subsequent collaboration could be structured in a manner that honours the independence and dignity of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the official position, but recommended that talks must proceed since a large portion of the country's HIV programmes relied on foreign aid.
"If specific concerns exist, including those relating to data governance or implementation frameworks, these can frequently be addressed through detailed discussion and mutually agreed protections," it commented.
This impasse highlights the ongoing challenges between receiving vital foreign assistance and safeguarding national sovereignty in an ever more interconnected world.